Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats

Brain Research

Volumn 1248, Issue , 2009, Pages 96-106

  El Mas, Mahmoud M ^a   Omar, Amal G ^a   Helmy, Mai M ^a   Mohy El Din, Mahmoud M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

2 adrenoceptor; Blood pressure; Clonidine; Cyclosporine; Guanabenz; I1 imidazoline receptor; Moxonidine; Rat

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; CYCLOSPORIN; EFAROXAN; GUANABENZ; HEXAMETHONIUM; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; PHENYLEPHRINE; PRAZOSIN; SODIUM CHLORIDE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; HEART RATE VARIABILITY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETERIZATION; CYCLOSPORINE; GANGLIONIC BLOCKERS; HEART RATE; HYPERTENSION; IMIDAZOLES; IMIDAZOLINE RECEPTORS; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; SYMPATHOLYTICS;

RATTUS;

EID: 57649149091     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.008     Document Type: Article

References (47)

1. 2-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230 (1984) 232-236
2. Bousquet P., Feldman J., Tibirica E., Bricca G., Greney H., Dontenwill M., Stutzmann J., and Belcourt A. Imidazoline receptors: a new concept in central regulation of the arterial blood pressure. Am. J. Hypertens. 5 (1992) 47S-50S
3. Chalmers J., and Pilowsky P. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J. Hypertens. 9 (1991) 675-694
4. Chiu P.J.S., Vemulapalli S., Sabin C., Rivelli M., Bernardino V., and Sybertz E.J. Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats. J. Pharmacol. Exp. Ther. 261 (1992) 994-999
5. Cohen D.J., Loertscher R., Rubin M.F., Tilney N.L., Carpenter C.B., and Storm T.B. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 101 (1984) 667-682
6. Diaz M.A., Cisneros C., Montejo J.C., Garcia C., Cantalapiedra J.A., and Perez F. Systemic arterial hypertension in the immediate postoperative period of liver transplantation. Transplant. Proc. 21 (1989) 3547-3548
7. Eid A., Perkins J.D., Rakela J., and Krom R.A. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year. Transplant. Proc. 21 (1989) 2238-2239
8. El-Mas M.M., and Abdel-Rahman A.A. Role of cardiac output in ethanol-evoked attenuation of centrally-mediated hypotension in conscious rats. Hypertension 30 (1997) 288-294
9. I-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 288 (1999) 455-462
10. El-Mas M.M., and Abdel-Rahman A.A. Role of the sympathetic control of vascular resistance in ethanol-clonidine hemodynamic interaction in SHRs. J. Cardiovasc. Pharmacol. 34 (1999) 589-596
11. 1-imidazoline receptor in ethanol counteraction of clonidine hypotension in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 38 (2001) 417-426
12. El-Mas M.M., Tao S., Carroll R.G., and Abdel-Rahman A.A. Ethanol-clonidine hemodynamic interaction in normotensive rats is modified by anesthesia. Alcohol 11 (1994) 307-314
13. El-Mas M.M., Afify E.A., Mohy El-Din M.M., Omar A.G., and Sharabi F.M. Testosterone facilitates the baroreceptor control of reflex bradycardia: role of cardiac sympathetic and parasympathetic components. J. Cardiovasc. Pharmacol. 38 (2001) 754-763
14. El-Mas M.M., Afify E.A., Omar A.G., and Sharabi F.M. Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J. Pharmacol. Exp. Ther. 301 (2002) 346-354
15. El-Mas M.M., Afify E.A., Omar A.G., and Sharabi F.M. Cyclosporine attenuates the autonomic modulation of reflex chronotropic responses in conscious rats. Can. J. Physiol. Pharmacol. 80 (2002) 766-776
16. Ernsberger P., Giuliano R., Willette R.N., and Reis D.J. Role of imidazole receptors in the vasodepressor responses to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253 (1990) 408-418
17. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264 (1993) 172-182
18. Gardiner S.M., March J.E., Kemp P.A., Fallgren B., and Bennett T. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats. Br. J. Pharmacol. 141 (2004) 634-643
19. Head G.A., and Burke S.L. Relative importance of medullary brain nuclei for the sympathoinhibitory actions of rilmenidine in the anaesthetized rabbit. J. Hypertens. 16 (1998) 503-517
20. Kawasaki H., and Takasaki K. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats. Arch. Int. Pharmacodyn. Ther. 289 (1987) 217-233
21. Langer S.Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32 (1981) 337-362
22. Lim H.C., Chong O.K., and Chan S.H. Characterization of alpha-adrenoceptors in the nucleus reticularis gigantocellularis involved in the cardiovascular depressant effects of guanabenz in the rat. Neuropharmacology 27 (1988) 243-249
23. Lyson T., McMullan D.M., Ermel L.D., Morgan B.J., and Victor R.G. Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 23 (1994) 667-675
24. Mason J. Pharmacology of cyclosporine (Sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol. Rev. 41 (1990) 423-434
25. Meyer-Lehnert H., and Schrier R. Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 13 (1989) 352-360
26. Moreira T.S., Takakura A.C., Menani J.V., Sato M.A., and Colombari E. Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension. Br. J. Pharmacol. 142 (2004) 765-771
27. Morgan B.J., Lyson T., Scherrer U., and Victor R.G. Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension 18 (1991) 458-466
28. Moss N.G., Powell S.L., and Falk R.J. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8222-8226
29. Nagahama S., Chen Y.F., Lindheimer M.D., and Oparil S. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat. J. Pharmacol. Exp. Ther. 236 (1986) 735-742
30. Niederberger W., Lemaire M., Maurer G., Nussbaumer K., and Wagner O. Distribution and binding of cyclosporin in blood and tissues. Transplant. Proc. 15 (1983) 2419-2421
31. Nishiyama A., Kobori H., Fukui T., Zhang G.X., Yao L., Rahman M., Hitomi H., Kiyomoto H., Shokoji T., Kimura S., Kohno M., and Abe Y. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 42 (2003) 754-760
32. Nurminen M.L., Culman J., Haass M., Chung O., and Unger T. Effect of moxonidine on blood pressure and sympathetic tone in conscious spontaneously hypertensive rats. Eur. J. Pharmacol. 362 (1998) 61-67
33. 2 and nitric oxide in CsA-induced hypertension. Prostaglandins Leukot. Essent. Fat. Acids 68 (2003) 233-238
34. Ponticelli C., Montagnino G., Aroldi A., Angelini C., Braga M., and Tarantino A. Hypertension after renal transplantation. Am. J. Kidney Dis. 21 (1993) 73-78
35. 1A and alpha2-adrenoceptor agonists in anesthetized cats. Br. J. Pharmacol. 98 (1989) 1157-1164
36. Rego A., Vargas R., Suarez K.R., Foegh M.L., and Ramwell P.W. Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium. J. Pharmacol. Exp. Ther. 254 (1990) 799-808
37. Scherrer U., Vissing S.F., Morgan B.J., Rollins J.A., Tindall R.S., Ring S., Hanson P., Mohanty P.K., and Victor R.G. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N. Engl. J. Med. 323 (1990) 693-699
38. Shaltout H.A., and Abdel-Rahman A.A. Cyclosporine induces progressive attenuation of baroreceptor heart rate response and cumulative pressor response in conscious unrestrained rats. J. Pharmacol. Exp. Ther. 305 (2003) 966-973
39. Shimizu H., Kumai T., and Kobayashi S. Involvement of tyrosine hydroxylase upregulation in cyclosporine-induced hypertension. Jpn. J. Pharmacol. 85 (2001) 306-312
40. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol. Ther. 93 (2002) 1-35
41. 2-Adrenoceptors: classification, localization, mechanisms and targets for drugs. J. Med. Chem. 25 (1982) 1389-1401
42. Van den Buuse M. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats. Eur. J. Pharmacol. 322 (1997) 191-199
43. 1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. J. Hypertens. 15 (1997) 117-125
44. Yaris E., and Tuncer M. Cyclosporin A and cremophor-EL augment renal vascular responses to various agonists and nerve stimulation. Arch. Int. Pharmacodyn. 329 (1995) 405-417
45. Ye S., Ozgur B., and Campese V.M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 51 (1997) 722-727
46. Ye S., Zhong H., Yanamadala V., and Campese V.M. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am. J. Hypertens. 15 (2002) 717-724
47. Zhang W., and Victor R.G. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am. J. Hypertens. 13 (2000) 999-1004